Ohio State Navbar

Research

Ongoing Studies


Ongoing Clinical Research Trials:
              
The Ohio State University Medical Center is a national leader in conducting clinical trials for prevention and treatment of various diseases, which includes diabetes. The Division of Endocrinology, Diabetes and Metabolism and the Diabetes and Metabolism Research Center conduct research for Type 1 and Type 2 diabetes both for NIH and industry sponsored studies.              

For information on the benefits and risks of participating in a clinical research trial, please click here.

The Division of Endocrinology, Diabetes and Metabolism and the DMRC are currently enrolling in the following clinical trials. Each study has specific requirements for enrolment. If you are interested in participating in any of the studies, please contact the person listed.

RegenerateA phase 3 clinical trial for patients diagnosed with NASH. Please contact Amber Anaya at 614-688-6257 should you be interested in participating.

PIONEER 6:  A clinical trial for patients with Type 2 Diabetes. You may qualify if you are older than 50 years and have had a prior cardiac event. Please contact Amber Anaya at 614-688-6257 should you be interested in participating.

Toujeo 2:  A clinical trial for people with type 2 diabetes who are insulin naïve patients who are currently on 2 or more oral diabetes medications. A1C must be between 8% and 11%. Please contact Amber Anaya at 614-688-6257 should you be interested in participating.

Toujeo 1: A clinical trial for patients with type 1 diabetes. You may qualify if you are using both basal and rapid-acting insulin with an A1c between 6.5 - 10%. Please contact Ashley Mintos at 614-688-6885 should you be interested in participating.

Pasireotide: Patients with Cushing’s disease and treated with Pasireotide alone and in combination with other therapies. Please contact Ashley Mintos at 614-688-6885 if interested

Harmony Outcomes:  A type 2 diabetes trial. You may qualify if you have a history of heart disease and an HbA1c > 7%. Please contact Ashley Mintos at 614-688-6885 if interested

TrialNet: study for family members who are related to someone who has Type 1 Diabetes. Eligibility qualifications include: immediate family ages 1-45, sibling, mother, father, child or ages 1-20 for nieces, nephews, aunts, uncle, and grandchildren.  If interested please call Angela Howell 614-688-6258.

Cortendo:  tudy for patients with Cushing’s syndrome.  Some eligibility qualifications include: over the age of 18, history of pituitary tumor and endogenous Cushing syndrome. If interested please contact Angela Howell 614-688-6258.

MPOWERED: study for patients with Acromegaly.  Some eligibility qualifications include: ages 18-75, biochemically controlled Acromegaly and currently taking long acting injections (SRL’s). If interested please contact Angela Howell 614-688-6258.